Optimum adjuvant trastuzumab duration for human epidermal growth factor receptor-2 positive breast cancer: a network meta-analysis of randomized trials
@article{TCR51235, author = {Ji Ma and Xiaofang Tang and Qiancheng Hu and Qingfeng Wang and Ye Chen and Xiaofen Li and Ting Luo and Dan Cao}, title = {Optimum adjuvant trastuzumab duration for human epidermal growth factor receptor-2 positive breast cancer: a network meta-analysis of randomized trials}, journal = {Translational Cancer Research}, volume = {10}, number = {4}, year = {2021}, keywords = {}, abstract = {}, issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/51235} }